Advances in Understanding How RhoB Regulates Akt Inhibition Efficacy in NSCLC.

Akgun, Nurullah; Halıcı, Zekai; Çadırcı, Elif

doi:10.2174/0115680096355061241115113703

Makale Tam Makale Uluslararası 2025

Advances in Understanding How RhoB Regulates Akt Inhibition Efficacy in NSCLC.

Nurullah Akgun, Zekai Halıcı, Elif Çadırcı

Current cancer drug targets 16.01.2025

DOI ile aç

Atıf için künye

Akgun, N., Halıcı, Z., & Çadırcı, E. (2025). Advances in Understanding How RhoB Regulates Akt Inhibition Efficacy in NSCLC. Current cancer drug targets. https://doi.org/10.2174/0115680096355061241115113703

BibTeX

@article{akgun2025-231979,
  author = {Akgun, Nurullah and Halıcı, Zekai and Çadırcı, Elif},
  title = {Advances in Understanding How RhoB Regulates Akt Inhibition Efficacy in NSCLC.},
  journal = {Current cancer drug targets},
  year = {2025},
  issn = {1568-0096},
  doi = {10.2174/0115680096355061241115113703},
  url = {https://akademik.atauni.edu.tr/yayinlar/231979-advances-in-understanding-how-rhob-regulates-akt-inhibition-efficacy-in-nsclc}
}